BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 28840741)

  • 1. [Insulin pump in type 2 diabetes: B-cell focused treatment].
    Picková K; Rušavý Z
    Vnitr Lek; 2017; 63(6):441-445. PubMed ID: 28840741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current role of short-term intensive insulin strategies in newly diagnosed type 2 diabetes.
    Xu W; Weng J
    J Diabetes; 2013 Sep; 5(3):268-74. PubMed ID: 23551748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin pump therapy in adults.
    Didangelos T; Iliadis F
    Diabetes Res Clin Pract; 2011 Aug; 93 Suppl 1():S109-13. PubMed ID: 21864741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fate of the beta-cell in the pathophysiology of type 2 diabetes.
    Campbell RK
    J Am Pharm Assoc (2003); 2009; 49 Suppl 1():S10-5. PubMed ID: 19801360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The comparison of insulin aspart and human soluble insulin used in insulin pump therapy in newly diagnosed type 2 diabetic patients].
    Li YB; Liu J; Liao ZH; Liao Y; Deng WP; Weng JP
    Zhonghua Yi Xue Za Zhi; 2005 Sep; 85(35):2472-6. PubMed ID: 16321271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection of pancreatic beta-cells: is it feasible?
    Bonora E
    Nutr Metab Cardiovasc Dis; 2008 Jan; 18(1):74-83. PubMed ID: 18096375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin requirement profiles of short-term intensive insulin therapy in patients with newly diagnosed type 2 diabetes and its association with long-term glycemic remission.
    Liu L; Ke W; Wan X; Zhang P; Cao X; Deng W; Li Y
    Diabetes Res Clin Pract; 2015 May; 108(2):250-7. PubMed ID: 25765670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of insulin pump therapy for type 2 diabetes mellitus.
    Landau Z; Raz I; Wainstein J; Bar-Dayan Y; Cahn A
    Diabetes Metab Res Rev; 2017 Jan; 33(1):. PubMed ID: 27189155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect and mechanism of transient continuous subcutaneous insulin infusion therapy on beta cell function, insulin resistance and vascular endothelial injury in newly diagnosed type 2 diabetes].
    Liu SP; Mo H; Liu BL; Tang WL; Deng XG; Su X; Yao L; Lin J; Feng Q; Peng J; Zhou ZG; Li YJ
    Zhonghua Nei Ke Za Zhi; 2010 May; 49(5):405-9. PubMed ID: 20646415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term intensified insulin treatment in type 2 diabetes: long-term effects on β-cell function.
    Retnakaran R; Zinman B
    Diabetes Obes Metab; 2012 Oct; 14 Suppl 3():161-6. PubMed ID: 22928577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. beta-cell failure in diabetes and preservation by clinical treatment.
    Wajchenberg BL
    Endocr Rev; 2007 Apr; 28(2):187-218. PubMed ID: 17353295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intensive insulin therapy in newly diagnosed type 2 diabetes.
    Retnakaran R; Drucker DJ
    Lancet; 2008 May; 371(9626):1725-6. PubMed ID: 18502278
    [No Abstract]   [Full Text] [Related]  

  • 13. Short-term intensive insulin therapy in type 2 diabetes mellitus: a systematic review and meta-analysis.
    Kramer CK; Zinman B; Retnakaran R
    Lancet Diabetes Endocrinol; 2013 Sep; 1(1):28-34. PubMed ID: 24622264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes: insulin pump therapy for type 2 diabetes mellitus.
    Pickup JC
    Nat Rev Endocrinol; 2014 Nov; 10(11):647-9. PubMed ID: 25112234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current issues in the treatment of type 2 diabetes. Overview of newer agents: where treatment is going.
    DeFronzo RA
    Am J Med; 2010 Mar; 123(3 Suppl):S38-48. PubMed ID: 20206731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incretin hormones and maturity onset diabetes of the young--pathophysiological implications and anti-diabetic treatment potential.
    Østoft SH
    Dan Med J; 2015 Sep; 62(9):. PubMed ID: 26324089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspects of insulin treatment.
    Bloomgarden ZT
    Diabetes Care; 2010 Jan; 33(1):e1-6. PubMed ID: 20040659
    [No Abstract]   [Full Text] [Related]  

  • 18. A cost-effectiveness analysis of sensor-augmented insulin pump therapy and automated insulin suspension versus standard pump therapy for hypoglycemic unaware patients with type 1 diabetes.
    Ly TT; Brnabic AJ; Eggleston A; Kolivos A; McBride ME; Schrover R; Jones TW
    Value Health; 2014 Jul; 17(5):561-9. PubMed ID: 25128049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Day and night glycaemic control with a bionic pancreas versus conventional insulin pump therapy in preadolescent children with type 1 diabetes: a randomised crossover trial.
    Russell SJ; Hillard MA; Balliro C; Magyar KL; Selagamsetty R; Sinha M; Grennan K; Mondesir D; Ekhlaspour L; Zheng H; Damiano ER; El-Khatib FH
    Lancet Diabetes Endocrinol; 2016 Mar; 4(3):233-243. PubMed ID: 26850709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Expert Opinion on Advanced Insulin Pump Use in Youth with Type 1 Diabetes.
    Bode BW; Kaufman FR; Vint N
    Diabetes Technol Ther; 2017 Mar; 19(3):145-154. PubMed ID: 28135116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.